HCPLive
Billed as "the world’s premier nephrology meeting," Kidney Week 2013 will attract more than 13,000 other kidney professionals from across the globe with “exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field” of nephrology.
American Society of Nephrology 2013 Annual Meeting (Kidney Week 2013)

American Society of Nephrology 2013 Annual Meeting (Kidney Week 2013) | ASN 2013

Conference Coverages

Higher All-Cause Mortality Associated with Hyponatremia in Chronic Kidney Disease
Higher All-Cause Mortality Associated with Hyponatremia in Chronic Kidney Disease
Study results show hyponatremia is closely associated with all-cause mortality in patients with chronic kidney disease (CKD), but few previous studies have examined this relationship.
Pattern of Opioid Analgesic Use among Patients with End-stage Renal Disease
According to the authors of a recent study, almost 50% of patients with end-stage renal disease (ESRD) say they have chronic pain, and over 75% of them rate it as being moderate to severe.
Why Nephrologists Exclude Patients from Referral for Kidney Transplant: A Survey
A recent anonymous survey among nephrologists suggests that patients' social support, ability to understand the transplant process, and age are the most important factors influencing nephrologists' decisions to exclude them from kidney transplant referral.
Opioid Analgesic Use among Dialysis Patients Is Increasing
A recent study suggests that dialysis patients' use of opioid analgesics (OAs) is widespread and exceeding historical limits, and that the patients who use opioids are staying on them longer.
Including Newer Biomarkers in Testing Improves Death Prediction in Chronic Kidney Disease
Though patients with chronic kidney disease (CKD) have variable risks of death, the population risk prediction tools that are currently available perform poorly.
In Hemodialysis Patients, Renin-Angiotensin System Inhibitors Reduce All-Cause Mortality Risk
A recent study found that drug regimens containing renin-angiotensin system (RAS) inhibitors are associated with a lower risk of cardiovascular and all-cause deaths among patients starting hemodialysis, compared to regimens containing only beta blockers (BBs).
Chronic Kidney Disease Patients with End-Stage Renal Disease Need Less Warfarin, More Monitoring for Bleeding
Patients who have chronic kidney disease (CKD) and end-stage renal disease (ESRD) require 20% less warfarin and more monitoring for bleeding than patients who have normal kidney function.

Most Popular

$vacMongoViewPlus$ $vAR$